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Abstract
Background: In Zambia, translocation of wildlife from National Parks to private owned game ranches demands that 
only animals free of infectious diseases that could adversely affect the expansion of the wildlife industry should be 
translocated to game ranches. Sarcoptes mange (Sarcoptes scarbiei) has been involved in the reduction of wildlife 
populations in some species.
Results: Sarcoptes mange (Sarcoptes scarbiei) was detected and eradicated from two herds of African buffalo (Syncerus 
caffer) calves captured in the Kafue GMA in July 2004 and August 2005. The overall prevalence was estimated at 89.5% 
(77/86). Sex had no influence on the occurrence and severity of the disease. Of the 86 calves used in the study, 72.1% 
had good body condition scores, 20.9% were fair and 7.0% were poor. Of the 77 infected calves, 53.2% were mildly 
infected, 28.6% were moderately and 18.2% were severely infected. Body condition score was correlated to the severity 
of the infection (r = 0.72, p < 0.000, n = 86) at capture. Eradication of Sarcoptes mites from the entire herd using 
ivermetcin was dependant on the severity of the infection. The overall ability of ivermectin to clear the infection after 
the first treatment was estimated at 81.8% (n = 77). It increased to 94.8% and 100% after the second and third 
treatments respectively.
Conclusion: This is the first report on the epidemiology and treatment of Sarcoptes mange in African buffaloes in 
Zambia. This study improves our understanding about Sarcoptes scabiei epidemiology and treatment which will have 
further applications for the safe animal translocation.
Background
Sarcoptic mange is a highly contagious disease affecting
humans [1,2], domestic animals [3] and wildlife [4]. The
disease is caused by Sarcoptes scabiei mites that burrow
in the epidermis of the skin where they form tunnels and
deposit their eggs and digestive secretions causing
intense skin irritations. The mites complete their lifecycle
within a few weeks giving rise to high densities reaching
up to 5000 mites/cm2 in some species [5]. This leads to
alopecia and hyperkeratosis of the skin [6]. The disease
has been associated with high morbidity and mortality
leading to population reductions in some species [7-10].
The efficacy of ivermectin in the treatment of Sarcoptes
mange in different wildlife species has been carried out
with variable responses [11-14]. Although the disease
affects various wildlife species [15,15], there are few
reports describing its epidemiology in African game. In
Zambia, it has been reported in humans and domestic
animals with limited reports on wildlife [16].
The expansion of the game ranching industry in Zam-
bia as an ex-situ  conservation strategy has led to the
translocation of several wildlife species from state owned
National Parks (NPs) and game management areas
(GMAs) to private owned game ranches in recent years.
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However, infectious diseases such as foot and mouth dis-
ease,  Sarcoptes  mange and bovine tuberculosis are a
major constraint to the translocation of wildlife [17]
because regulations demand that only animals not
infected with such infectious diseases should be translo-
cated to game ranches. This paper discusses the clinical
observations made and the treatment regime used to
eradicate sarcoptic mange from the entire herd of buffalo
calves captured in the Kafue GMA prior to translocation.
Methods
Animal data
The Study Was Carried Out At Nanzhila (26°03'E,
15°44'S) located on the western end of the Kafue flats
GMA which is a wetland area designated as Ramsar Site
No. 530 [18]. The area supports a transhumance grazing
system for the traditional livestock farmers from the sur-
rounding upland areas by providing grazing pastures for
cattle in the dry season. GMAs are considered to be buf-
fer zones being located between NPs and communal
lands and are also referred to as livestock/wildlife inter-
face areas because the co-existence of domestic animals
and wildlife is permitted in these areas [19]. In August
2004 a total of 48 African buffalo calves were captured
and used in the study while 38 were used in July 2005
with permission of the Zambia wildlife Authority
(ZAWA) who are the custodians of wildlife in Zambia
(Project authorization ref: 006/68-07-05). Age was esti-
mated at four to six months for all calves using tooth
development [20]. The calves were kept in quarantine
facilities for 90 days and were sampled at 30 days inter-
vals. At every sampling, calves were immobilized using
M99 (etorphine hydrochloride, Novartis Ltd., Animal
Health, South Africa) and reversed using M5050 revivon
(dreprenorphine, Novartis SA Ltd., Animal Health, South
Africa).
Sarcoptes diagnosis and treatment
The severity of the disease was classified into three cate-
gories as mild (+), modera te (++) and severe (+++) as
described by Pence et al [21]. The mild group involved
calves with focal lesions covering small patches of the
body surface. Most of the lesions observed in this group
were in the initial phase and they included erythema,
pruritis, encrustations, suppuration and alopecia. The
most affected body parts were the forehead, shoulders,
hump and hock joints. The moderate group involved ani-
mals with actively progressing lesions covering large
areas extending to almost half of the body surface. There
were large surfaces of erythema, pruritis, alopecia, scabs,
parakeratosis and fissures on some of the animals. Suffice
to mention that some of the lesions observed in this
group were similar to those observed in the mild group
only that in the moderate group lesions were progressive
and diffuse covering large areas. Severe groups were ani-
mals whose lesions covered more than half of the body
surface. Alopecia, parakeratosis, thick and wrinkled skin
surfaces were more pronounced in this group than in the
mild and moderate groups. Body condition score was
recorded as good (++), fair (+) or poor (-) depending on
the degree of emaciation and skin pliability. Highly ema-
ci a t ed  a n i m a ls  h a vi n g  l i t t l e  m u sc l e  wi t h  n o  s i gn  o f  fa t
deposits and the skin falling slowly or staying in a fold
after pulling a portion on the neck were scored poor (-).
Animals having moderate deposition of muscle with the
skin of the neck folding moderately faster than those in
poor body conditions were scored as fair (+) while ani-
mals with excess fat and muscle with the skin quickly fall-
ing to its original position after the pliability test were
scored as good (++).
Skin scrapings were collected at every sampling. All
claves were treated with 200 μg kg-1 ivermectin (Novartis
SA Ltd., Animal Health) at each sampling time point irre-
spective of whether they had mites detected or not. They
were translocated to game ranches within three days after
being declared free of mites after the fourth screening
test.
At the School of Veterinary Medicine at the University
of Zambia, skin scrapings were examined after treatment
with 20% potassium hydroxide [22]. Identification of
mites was carried out as described elsewhere [23]. Sex,
age, body condition score, severity score of the clinical
condition and laboratory results for each calf were
recorded in Exel® sheets at each sampling time point. Data
was analyzed using STATA SE/10 for windows (Stata
Corp. College Station, TX, USA, http://www.stata.com).
Chi-square was used to test the measures of association
between sex and occurrence of the disease while the
Pearson's correlation coefficient test was used to measure




Sex ratio (male:female) was estimated at 1:12. Our obser-
vations indicate that sex had no influence on the occur-
rence (χ2 = 0.093, p > 0.70) and severity (χ2 = 0.70, p >
0.70) of the disease. Overall prevalence for the two herds
was estimated at 89.5% (77/86) at capture (Table 1). Of
the 86 calves used in the study, 72.1% had good body con-
dition score, 20.9% were fair and 6.9% were poor at cap-
ture (Table 2). Of the 77 infected calves, 53.2% were
mildly infected, 28.6% were moderately and 18.2% were
severely infected at capture. Body condition score was
positively correlated to the severity of the infection (r =
0.72, p < 0.000, n = 86) at capture.
Sarcoptes mite treatment
Decrease in the number of infected calves after the first
treatment was related to the severity of the infectionMunang'andu et al. BMC Veterinary Research 2010, 6:29
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observed at capture (Table 1). Of the 41 mildly infected
calves, only two had Sarcoptes mites after the first treat-
ment (4.98%) while in the moderately affected group
45.45% (10/22) needed a second treatment for the mites
to be eliminated. In the severely affected group, there was
a gradual decline with 28.57% (4/14) not having mites
after the first treatment, 42.86% (10/14) after the second
treatment and another 28.57% (4/14) after the third treat-
ment. The overall drug ability to clear the infection was
estimated at 81.8% (n = 77) after the first treatment. It
increased to 94.8% after the second treatment and
reached 100% after the third treatment. The calves were
translocated to game ranches within three days after the
fourth treatment after they were declared free of Sarcop-
tes mange.
Discussion
In Zambia, sarcoptic mange has been reported in sitat-
unga (Tragelaphus spekii), hartebeest (Alcephelus lichten-
steini) and silver-backed-jackal (Canis mesomelas) in
wildlife [16]. In domestic animals the disease has been
reported in cattle, goats and pigs [16]. It has not been
reported from the African buffalo and no comprehensive
study has been carried out describing the clinical findings
in wildlife in Zambia. In line with observations made by
Pence and Ueckermann [24], our findings indicate that
clinical conditions vary between animals depending on
the severity of the infection. Tikaram and Ruprah
[25]observed that the incidence of sarcoptic mange was
highest in young animals below one year. They noted that
prevalence decreased with advancement of age and that
Table 1: Treatment regime and detection of mites at different sampling time points.
Number of calves detected with presence of Sarcoptes scabiei 
mites at;
Year Number of 
calves
Severity of skin 
infection











2004 48(45)* Mild + 25 2 0 0
Moderate ++ 12 4 0 0
S e v e r e+ + + 8620
2005 38(32)* Mild + 16 0 0 0
Moderate ++ 10 4 0 0
S e v e r e+ + + 6420
Totals 86(77)* 77 14 4 0
*Number of calves infected with Sarcoptes mange at capture (first sampling).
Table 2: Body condition score of the calves at different sampling time points.
Body score condition at different sampling time points
Year n Category Score Day 1 Day 30 Day 60 Day 90
Number of calves Number of calves Number of calves Number of calves
2004 48 Good ++ 35 47 48 48
Fair + 11 1 - -
Poor - 2 - - -
2005 38 Good ++ 27 36 38 38
Fair + 7 2 - -
Poor - 4 - - -
Totals 86 86 86 86 86Munang'andu et al. BMC Veterinary Research 2010, 6:29
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sex had no influence on the incidence of the disease [25].
The high prevalence 89.5%(77/86) obtained in the pres-
ent study could be attributed to the fact that the animals
involved were young ranging between four and six
months of age at capture. We also observed that sex had
no influence on the occurrence of the disease in the
calves.
Fain et al [26] postulated that Sarcoptes mange origi-
nated as a human parasite that spread to domestic ani-
mals and subsequently transmitted to various wildlife
species by contact with their domestic counterparts. It is
not known how Sarcoptes scabiei was introduced in buf-
falo herds in the Kafue GMA although the disease has
been present in domestic animals in the area [16]. Studies
have shown that the transmission of mange was density
dependant being more prevalent during times of higher
environmental stress such as drought [27,28]. In the pres-
ent study, the high prevalence of Sarcoptes mange (89.5%,
n = 86) reported in the calves could have been exacer-
bated by stress factors caused by the scarcity of water and
grazing pastures during the dry season in the months of
May to October on the Kafue flats. Livestock owners in
the upland areas surrounding the Kafue flats practice a
transhumance grazing system by moving their animals
into the flats during the dry season leading to the sharing
of grazing pastures and water between wildlife and live-
stock. This impacts a high population density on the flats.
It is likely that Sarcoptes mange could have been trans-
mitted from livestock to wildlife during such contacts.
However, to fully understand the factors responsible for
the epidemiology and transmission of the disease
between species in the Kafue flats it is imperative that
wildlife and livestock surveys be synchronized involving
m o l e c u l a r  s t u d i e s  o f  t h e  g e n e  f l o w  o f  t h i s  p a r a s i t e
between different host species and geographical localities
[29]. Perez et al [30] observed that Sarcoptes mange cases
w e r e  h i g h e r  i n  t h e  c o l d  s e a s o n  r e d u c i n g  i n  t h e  h o t
months in summer when conditions were unfavorable for
the survival of the mites. In Zambia, the cold season is in
the months of June to August and this could have contrib-
uted to the increase in the number of calves infected
given the timing of the present study that calves were
captured in the cold months of August 2005 and July
2005. Treating the calves for the subsequent three
months means that the treatment regime extended into
the hot months of September to November which could
have impacted negatively on the survival of the mites. It is
likely that climatic factors had confounding effects on the
treatment regime used in the current study. However,
there is a need to carry out more detailed studies in order
to determine the effect of climate on the epidemiology of
sarcoptic mange on the Kafue basin.
The efficacy of ivermectin in the treatment of Sarcoptes
mange in domestic animal has been studied by different
scientists with some studies showing high responses after
the first treatment [31,32] although other studies have
shown a gradual decrease in the number of mites after
multiple doses of ivermetcin administered at regular
intervals [33]. In Wildlife, there have been variable
responses on the treatment of Sarcoptes  mange using
ivermectin in different animal species. Leon-Vizcaino et
al [34] managed to eliminate the Sarcoptes mites from
Spanish ibex (Capra pyrenaica) in the early stages of the
infection, although double injections with high doses of
ivermectin did not yield success in chronically infected
animals. However, Skerratt [35] reported a complete res-
olution of clinical signs in wombats (Wombatus ursinus)
after three injections of ivermectin administered 10 days
apart although mites were not completely eliminated
until the wambots were given a second regime of treat-
ment. Yeruham et al [36] reported of complete recovery
of severely infected wild ruminants kept in zoological
gardens after mutlitple treament using ivermectin admin-
istered orally at regular intervals. These observations
indicate that Sarcoptes mites can be eliminated from wild
animals kept in captivity using ivermectin. Besides, iver-
mectin has been shown to be an effective drug for treat-
ing various endoparasites and parasitic skin diseases [37].
In the present study, we observed a gradual decrease in
the number of infected calves from the first to the third
treatment (Table 1). Our observations indicate that eradi-
cation of Sarcoptes scabiei mites using ivermectin was
dependant on the severity of the infection (Table 1) simi-
lar to observations made by Skerratt [35].
Conclusion
Sarcoptes  mites were eradicated from African buffalo
calves captured from the Kafue game management area
after the third treatment indicating that it is possible to
eradicate some infectious diseases from infected wildlife
populations prior to translocation by using the screening
and treatment method. Hence, the risk of introducing
Sarcoptes  mange to naïve wildlife populations on the
game ranches was avoided. Suffice to mention that such
disease eradication methods are expensive as they require
frequent immobilization of animals. Prolonged keeping
of wildlife in captivity imposes a lot of stress on the ani-
mals. Therefore, we recommend that highly potent drugs
aimed at reducing the need for repeat treatments should
be explored for use in wildlife medicine. In addition, dis-
ease control strategies involving less strenuous handling
procedures should be used with a view of promoting the
success of ex-situ conservation.
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